We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Evgen Pharma Plc | LSE:EVG | London | Ordinary Share | GB00BSVYN304 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.80 | 0.75 | 0.85 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 422k | -4.04M | -0.0147 | -0.51 | 2.06M |
Date | Subject | Author | Discuss |
---|---|---|---|
10/11/2023 11:26 | Given the sale price I'm being offered all of todays 264k are buys. Someone getting bargains but I can't possibly add more as much as I'd like to | markth126 | |
07/11/2023 16:15 | OT I agree better to buy £500 worth of stock at this price, as someone seems to have done today. | clocktower | |
07/11/2023 16:01 | I certainly won't be giving £500 to some website I've never heard of, to tell me nothing that isn't already in the public domain. | on target | |
07/11/2023 15:57 | An educated opinion on the future potential is not something EVG could comment on at this time. The results that everyone expects should answer that question but until then one can only listen to experts in the field as to the chances of success. However, there has been a canny buyer that picks up stock as the price slides - in fact the last sell of around 400k the other week - half was quickly taken up but they leave some on the table in hope of picking up more at this sort of level it seems to me. | clocktower | |
07/11/2023 15:45 | Would they publish anything of market relevance without EVG reporting it at the same time? I think not | markth126 | |
07/11/2023 15:18 | If it makes good reading then I thought it would be valuable to anyone with a big holding but then if it's not I guess it would only be upsetting. However,would they publish and charge £500.00 to deliver bad news - I think not. 😊 | clocktower | |
07/11/2023 13:12 | Not sure what the report says about the outcome expectation as it's £500 . | markth126 | |
07/11/2023 08:00 | I notice breast cancer prevention drugs are all over the papers again today, unfortunately not this one yet. Still it may attract interest I guess. | clocktower | |
06/11/2023 08:58 | I think you'll start to see steady buying when it gets to 1.4p | paulhudd | |
02/11/2023 16:55 | Crickey, Alf we'd be in a sorry state of every CEO had to justify their share price performance in this market. Most MedTech stocks have been hammered | hatfullofsky | |
02/11/2023 13:03 | Well the market is clearly seeing through all the bods Bullsxxt, such optimism but that doesn't stretch to them buying in. Please don't invest on what the new CFO was saying about adding to shareholder value, this lot are only in it for themselves. I would have expected them to at least acknowledge the dire share price performance over the last 9 months, but no it was the usual promising the earth drivel to entice more unsuspecting punters. Aim company and board at its worst. | kingalf | |
02/11/2023 11:27 | Back where we were with that sell of almost 400k and I am not sure about them being swept up in the current climate W. | clocktower | |
02/11/2023 10:07 | I think that volume sell just a Bored PI. Will be swept up later | wololol | |
02/11/2023 09:28 | I was thinking exactly the same Wololol, finger crossed | hatfullofsky | |
02/11/2023 09:05 | Nice and quiet here on the western front. Looks like global markets and AXX share may have bottomed as interest rates freeze and should fall start of next year. Selling has dried up here so any buys should push it upwards. | wololol | |
31/10/2023 19:37 | Any phase 3 is no guarantee of success look at POLX | hatfullofsky | |
31/10/2023 19:35 | Any investment in a £5m, pre-revenue, Phase 1 company is a gamble. But you have to be in it to win it, so many like myself an Knight will have a basket of moon shots, it only takes one to pay for the others and some | hatfullofsky | |
31/10/2023 18:14 | Gambler or not, one thing is for certain, he must regret the day Evgen first came to his attention. Massive paper loss, will he throw in the towel so as to offset it against tax. That would keep a lid on any rise. | kingalf | |
31/10/2023 13:50 | Right now I would take 2.5p which is more than I paid for the small number I bought back after selling at circa 2.5p and taking a hefty loss. | clocktower | |
31/10/2023 13:43 | All premature talk of buyouts etc. 8p is not what I've been here for the last 3 years for. | markth126 | |
31/10/2023 13:15 | The question is what would shareholders accept. I'd take 8p so 4x where we are now that's reasonable, although some would argue it's worth a lot more. | wololol | |
31/10/2023 12:57 | hat - I am sure they have an insight to the potential by now, and before they make any further milestone payments it might well be in their best interest to make an offer that might be accepted by most stakeholders at this point in time, to save themselves a huge amount and likely benefit from other research that is being carried out. While we are gamblers, those that have deep knowledge in the pharma field, invest for what they truly believe will be long term benefits not only to patients but to themselves as well. Your not going to tell me that the likes of J R Kight whom holds 12% is a gambler. | clocktower | |
31/10/2023 11:48 | Stalicia would be crazy TO buy the company now with only phase 1/1b complete. They're not gamblers like us. | hatfullofsky | |
31/10/2023 07:58 | A takeover below 20 million quid would be of no interest to me. If it works, presumably the key shareholders would want considerably more than that anyway, and if it does not, 20 million would be a pipedream anyway. Mark: I am sorry to say that I simply do not believe that the window to buy shares here has been closed all this time. But I remain here for those results, in spite of the BOD. GLA. | lovewinshatelosses | |
31/10/2023 07:51 | Yes a takeover is likely hence why building a position at low levels. Lots of AIM companies being snapped up at the moment. Lots of news flow due in the next couple of months also. If the drug successfully manipulates the gene mRNA from their findings as intended then the share price will go ballistic. Not long to find out as well. | wololol |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions